Rational Advisors LLC decreased its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 87.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,708 shares of the company’s stock after selling 18,662 shares during the period. Rational Advisors LLC’s holdings in Colgate-Palmolive were worth $198,000 at the end of the most recent quarter.
A number of other hedge funds also recently bought and sold shares of CL. Vision Capital Management Inc. increased its stake in Colgate-Palmolive by 181.0% in the first quarter. Vision Capital Management Inc. now owns 17,310 shares of the company’s stock valued at $1,267,000 after buying an additional 11,150 shares in the last quarter. Hamel Associates Inc. boosted its position in Colgate-Palmolive by 150.0% in the first quarter. Hamel Associates Inc. now owns 54,130 shares of the company’s stock valued at $3,961,000 after buying an additional 32,475 shares during the last quarter. Independence Trust CO boosted its position in Colgate-Palmolive by 3.3% in the first quarter. Independence Trust CO now owns 41,274 shares of the company’s stock valued at $3,021,000 after buying an additional 1,328 shares during the last quarter. Assetmark Inc. boosted its position in Colgate-Palmolive by 1.7% in the first quarter. Assetmark Inc. now owns 4,545 shares of the company’s stock valued at $333,000 after buying an additional 75 shares during the last quarter. Finally, Quantitative Investment Management LLC acquired a new position in Colgate-Palmolive during the first quarter valued at about $10,956,000. 73.85% of the stock is owned by hedge funds and other institutional investors.
Colgate-Palmolive Company (CL) opened at 71.26 on Friday. The stock has a market cap of $62.77 billion, a price-to-earnings ratio of 26.48 and a beta of 0.80. Colgate-Palmolive Company has a 52 week low of $63.43 and a 52 week high of $77.27. The firm’s 50 day moving average price is $72.84 and its 200-day moving average price is $72.74.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, July 21st. The company reported $0.72 EPS for the quarter, meeting the consensus estimate of $0.72. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The business had revenue of $3.83 billion for the quarter, compared to analysts’ expectations of $3.89 billion. During the same period in the previous year, the company posted $0.70 EPS. Colgate-Palmolive’s revenue was down .5% on a year-over-year basis. Analysts expect that Colgate-Palmolive Company will post $2.89 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, August 15th. Stockholders of record on Tuesday, July 18th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.25%. The ex-dividend date is Friday, July 14th. Colgate-Palmolive’s dividend payout ratio is currently 59.48%.
COPYRIGHT VIOLATION WARNING: “Colgate-Palmolive Company (CL) Shares Sold by Rational Advisors LLC” was first reported by Community Financial News and is owned by of Community Financial News. If you are accessing this story on another site, it was illegally copied and reposted in violation of United States & international copyright and trademark laws. The original version of this story can be accessed at https://www.com-unik.info/2017/08/12/rational-advisors-llc-has-198000-stake-in-colgate-palmolive-company-cl-updated-updated.html.
Several research firms have issued reports on CL. Bank of America Corporation boosted their target price on Colgate-Palmolive from $78.00 to $80.00 and gave the stock a “buy” rating in a research report on Wednesday, May 31st. BidaskClub cut Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Saturday, June 24th. Vetr cut Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 target price on the stock. in a research report on Wednesday, May 17th. Royal Bank Of Canada restated a “hold” rating and issued a $74.00 price target on shares of Colgate-Palmolive in a report on Thursday, May 25th. Finally, Jefferies Group LLC assumed coverage on Colgate-Palmolive in a report on Tuesday, April 18th. They set a “hold” rating and a $78.00 target price on the stock. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $75.82.
In other news, Vice Chairman Franck J. Moison sold 35,000 shares of the business’s stock in a transaction on Monday, August 7th. The shares were sold at an average price of $71.52, for a total transaction of $2,503,200.00. Following the transaction, the insider now directly owns 201,411 shares in the company, valued at approximately $14,404,914.72. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Patricia Verduin sold 3,833 shares of the business’s stock in a transaction on Thursday, June 15th. The shares were sold at an average price of $75.67, for a total transaction of $290,043.11. Following the transaction, the insider now owns 53,022 shares in the company, valued at $4,012,174.74. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 203,969 shares of company stock worth $14,711,068. 1.02% of the stock is currently owned by corporate insiders.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
What are top analysts saying about Colgate-Palmolive Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Colgate-Palmolive Company and related companies.